Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

McMaster University

$25,000.00

Model-based development and scale-up of chromatographic separation processes

FY 2013-14

Summary
Biopharmaceutical products such as monoclonal antibodies, enzymes and interferons are increasingly being added to the repertoire of life saving drugs available to physicians for treating life-threatening ailments such as cancer, cardiac diseases and viral infections. As with other pharmaceutical products, these need to be available in highly pure form for their intended therapeutic applications. Biopharmaceuticals are very expensive due to a combination of factors such as high development and manufacturing cost, and relatively low shelf-life. For a typical product such as a monoclonal antibody, purification cost accounts for almost 60-80% of the total manufacturing cost. Most biopharmaceuticals are purified using column or membrane-based chromatography. While chromatography is widely used in the industry, it is quite difficult to scale-up. This is due to the fact that any chromatographic separation involves the complex interplay between adsorption (i.e. thermodynamics) and mass transport of material (i.e. kinetics). Improperly scaled-up processes can be extremely inefficient and this can have a detrimental effect on process economics. The objective of this project is to understand the thermodynamic and kinetic contributions in chromatographic purification of biopharmaceuticals such as monoclonal antibodies. Based on an understanding of these individual contributing factors, models for scale-up of chromatographic purification processes for these products will be developed. Such models will be useful in designing and developing cost-effective purification processes and thereby increase manufacturing efficiency in the biopharmaceutical industry.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
453248-2013
Name nom
Ghosh, Raja
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Model-based development and scale-up of chromatographic separation processes
Keyword
NSERC
Application summary
Biopharmaceutical products such as monoclonal antibodies, enzymes and interferons are increasingly being added to the repertoire of life saving drugs available to physicians for treating life-threatening ailments such as cancer, cardiac diseases and viral infections. As with other pharmaceutical products, these need to be available in highly pure form for their intended therapeutic applications. Biopharmaceuticals are very expensive due to a combination of factors such as high development and manufacturing cost, and relatively low shelf-life. For a typical product such as a monoclonal antibody, purification cost accounts for almost 60-80% of the total manufacturing cost. Most biopharmaceuticals are purified using column or membrane-based chromatography. While chromatography is widely used in the industry, it is quite difficult to scale-up. This is due to the fact that any chromatographic separation involves the complex interplay between adsorption (i.e. thermodynamics) and mass transport of material (i.e. kinetics). Improperly scaled-up processes can be extremely inefficient and this can have a detrimental effect on process economics. The objective of this project is to understand the thermodynamic and kinetic contributions in chromatographic purification of biopharmaceuticals such as monoclonal antibodies. Based on an understanding of these individual contributing factors, models for scale-up of chromatographic purification processes for these products will be developed. Such models will be useful in designing and developing cost-effective purification processes and thereby increase manufacturing efficiency in the biopharmaceutical industry.